ATE455097T1 - Neue derivate von 4,4'-dithiobis-(3-aminobutan-1- sulfonaten) und diese enthaltende zusammensetzungen - Google Patents
Neue derivate von 4,4'-dithiobis-(3-aminobutan-1- sulfonaten) und diese enthaltende zusammensetzungenInfo
- Publication number
- ATE455097T1 ATE455097T1 AT04786279T AT04786279T ATE455097T1 AT E455097 T1 ATE455097 T1 AT E455097T1 AT 04786279 T AT04786279 T AT 04786279T AT 04786279 T AT04786279 T AT 04786279T AT E455097 T1 ATE455097 T1 AT E455097T1
- Authority
- AT
- Austria
- Prior art keywords
- aminobutane
- dithiobis
- sulfonates
- compositions containing
- containing same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/64—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton
- C07C323/66—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and sulfur atoms, not being part of thio groups, bound to the same carbon skeleton containing sulfur atoms of sulfo, esterified sulfo or halosulfonyl groups, bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/30—Phosphinic acids R2P(=O)(OH); Thiophosphinic acids, i.e. R2P(=X)(XH) (X = S, Se)
- C07F9/32—Esters thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0309700A FR2858617A1 (fr) | 2003-08-06 | 2003-08-06 | Derives de 4',4'-dithiobis-(3-aminobutane-1-sulfonate-1- sulfonates) nouveaux et compositions les contenant |
PCT/FR2004/002106 WO2005014535A1 (fr) | 2003-08-06 | 2004-08-06 | Derives de 4,4’-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE455097T1 true ATE455097T1 (de) | 2010-01-15 |
Family
ID=34073059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04786279T ATE455097T1 (de) | 2003-08-06 | 2004-08-06 | Neue derivate von 4,4'-dithiobis-(3-aminobutan-1- sulfonaten) und diese enthaltende zusammensetzungen |
Country Status (14)
Country | Link |
---|---|
US (1) | US7582797B2 (de) |
EP (1) | EP1651596B1 (de) |
JP (1) | JP4718461B2 (de) |
AT (1) | ATE455097T1 (de) |
CA (1) | CA2533432C (de) |
CY (1) | CY1109950T1 (de) |
DE (1) | DE602004025119D1 (de) |
DK (1) | DK1651596T3 (de) |
ES (1) | ES2339354T3 (de) |
FR (1) | FR2858617A1 (de) |
PL (1) | PL1651596T3 (de) |
PT (1) | PT1651596E (de) |
SI (1) | SI1651596T1 (de) |
WO (1) | WO2005014535A1 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2931151A1 (fr) * | 2008-05-13 | 2009-11-20 | Pharmaleads Soc Par Actions Si | Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique |
WO2010014943A2 (en) * | 2008-08-01 | 2010-02-04 | Bioxiness Pharmaceutics, Inc. | Methionine analogs and methods of using same |
EP2439192A1 (de) * | 2010-10-07 | 2012-04-11 | Quantum Genomics | Verfahren zur Herstellung von (3S,3S') 4,4'-disulfandiylbis (3-aminobutan 1-sulfonsäure) |
HUE033403T2 (en) * | 2011-12-21 | 2017-11-28 | Quantum Genomics | Combination with (3S, 3S ') - 4,4'-disulfandyl-bis (3-aminobutane-1-sulfonic acid) and a second antihypertensive agent |
EP2722327A1 (de) | 2012-10-22 | 2014-04-23 | Quantum Genomics | Kristalline Phase von (3S,3S') 4,4'-disulfandiylbis (3-Aminobutan 1-Sulfonsäure) mit L-Lysin |
JP2017532348A (ja) * | 2014-10-17 | 2017-11-02 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション | 新規な小分子抗癌剤 |
TW202100146A (zh) * | 2019-03-11 | 2021-01-01 | 法商量子基因科技有限公司 | 用於治療高血壓或心衰竭的化合物及包含其之組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CO5021134A1 (es) * | 1998-05-01 | 2001-03-27 | Abbott Lab | Inhibidores beta-aminoacidos substituidos de aminopeptida- sa-2 metionina |
US6919307B2 (en) * | 2000-11-01 | 2005-07-19 | Praecis Pharmaceuticals, Inc. | Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
JP2005508841A (ja) * | 2001-03-29 | 2005-04-07 | スミスクライン・ビーチャム・コーポレイション | 化合物および方法 |
-
2003
- 2003-08-06 FR FR0309700A patent/FR2858617A1/fr not_active Withdrawn
-
2004
- 2004-08-06 PL PL04786279T patent/PL1651596T3/pl unknown
- 2004-08-06 SI SI200431385T patent/SI1651596T1/sl unknown
- 2004-08-06 DK DK04786279.2T patent/DK1651596T3/da active
- 2004-08-06 WO PCT/FR2004/002106 patent/WO2005014535A1/fr active Application Filing
- 2004-08-06 ES ES04786279T patent/ES2339354T3/es active Active
- 2004-08-06 JP JP2006522380A patent/JP4718461B2/ja not_active Expired - Fee Related
- 2004-08-06 PT PT04786279T patent/PT1651596E/pt unknown
- 2004-08-06 US US10/567,362 patent/US7582797B2/en active Active
- 2004-08-06 DE DE602004025119T patent/DE602004025119D1/de active Active
- 2004-08-06 EP EP04786279A patent/EP1651596B1/de active Active
- 2004-08-06 AT AT04786279T patent/ATE455097T1/de active
- 2004-08-06 CA CA2533432A patent/CA2533432C/fr not_active Expired - Fee Related
-
2010
- 2010-03-23 CY CY20101100285T patent/CY1109950T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
PL1651596T3 (pl) | 2010-08-31 |
CA2533432A1 (fr) | 2005-02-17 |
US20060205695A1 (en) | 2006-09-14 |
ES2339354T3 (es) | 2010-05-19 |
EP1651596B1 (de) | 2010-01-13 |
DK1651596T3 (da) | 2010-05-10 |
SI1651596T1 (sl) | 2010-06-30 |
US7582797B2 (en) | 2009-09-01 |
CA2533432C (fr) | 2013-05-21 |
WO2005014535A1 (fr) | 2005-02-17 |
CY1109950T1 (el) | 2014-09-10 |
FR2858617A1 (fr) | 2005-02-11 |
EP1651596A1 (de) | 2006-05-03 |
JP2007501204A (ja) | 2007-01-25 |
PT1651596E (pt) | 2010-04-16 |
DE602004025119D1 (de) | 2010-03-04 |
JP4718461B2 (ja) | 2011-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200600294A1 (ru) | [1,8] нафтиридин-2-оны и родственные соединения для лечения шизофрении | |
BG66084B1 (bg) | Циклопентаноиндоли, състави,съдържащи такива съединения и използването им | |
DE60224928D1 (de) | Dermatologische und kosmetische zusammensetzungen enthaltend ein furfurylderivat | |
EA200601002A1 (ru) | 6-алкенил и 6-фенилалкил замещённые 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы | |
CY1111050T1 (el) | Φωσφονικα, μονοφωσφοναμιδικα, διφωσφοναμιδικα για την αγωγη των ιϊκων παθησεων | |
ATE433447T1 (de) | Pyrimiidinverbindungen | |
DK2014304T3 (da) | Kolonrensende sammensætninger | |
IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
EA200301142A1 (ru) | Производные гетероциклилокси-, -тиокси- и -аминобензазола в качестве лигандов 5-гидрокситриптамина-6 | |
DE60324544D1 (de) | Muskarin antagonisten | |
EA200600971A1 (ru) | Применение замещённых 2 - аминотетралинов для профилактического лечения болезни паркинсона | |
CY1109950T1 (el) | Νεα παραγωγα 4,4-διθειοδις-(3-αμινοβουτανιο-1-σουλφονικων) και συνθεσεις που τα περιεχουν | |
EA200500244A1 (ru) | Тетрапропиламмония тетратиомолибдат и родственные соединения для антиангиогенной терапии | |
HK1081194A1 (en) | 6-amino-1h-indazole compounds as phosphodiesterase4 inhibitors, pharmaceutical compositions compris ing the same, and use thereof | |
DE60221425D1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren | |
DK1373220T3 (da) | Benzimidazoler, som er nyttige ved behandling af seksuel dysfunktion | |
BR0105563A (pt) | Derivados e análogos de galantamina | |
DE60215368D1 (de) | Pyranderivate als inhibitoren von ace und nep | |
EA200601687A1 (ru) | Тетрагидроизохинолиновые и тетрагидробензазепиновые производные (варианты), фармацевтическая композиция и фармацевтический набор, лекарственное и эталонное средство для тест-систем на их основе, способ лечения и профилактики заболевания, при котором благоприятна понижающая регуляция или ингибирование экспрессии или функции рецептора igf-1 | |
AP2001002188A0 (en) | 5HT1 antagonists for antidepressant therapy. | |
ATE517626T1 (de) | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen | |
EA200600316A1 (ru) | ПРОИЗВОДНЫЕ 3-НИТРОПИРАЗОЛО[1,5-a]ПИРИМИДИНОВ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ИСПОЛЬЗУЕМЫЕ В НЕМ ПРОМЕЖУТОЧНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), ЛЕКАРСТВЕННОЕ СРЕДСТВО (ВАРИАНТЫ) И СПОСОБ ЛЕЧЕНИЯ ИЛИ ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, СВЯЗАННЫХ С МОДУЛЯЦИЕЙ РЕЦЕПТОРА ГАМК(ВАРИАНТЫ) | |
EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
DE60136706D1 (de) | Ycin-acryloyl derivate und antimetabolische mitteln |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1651596 Country of ref document: EP |